Iran War: Global M&A Delays Expected, Indian Deal Flow Unlikely to Halt

A Lazard Inc. executive stated that the Iran war would likely delay M&A deal timelines but not derail overall activity. This implies that while the geopolitical uncertainty might cause a pause in some transactions, the fundamental drivers for mergers and acquisitions remain intact.

For Indian markets, this perspective is relevant for companies engaged in or planning cross-border M&A, especially those seeking foreign investment or looking to acquire overseas assets. Delays can impact capital allocation, integration plans, and short-term stock performance for companies involved in such deals.

While no specific Indian stocks are named, companies in sectors like IT services (e.g., TCS, INFY, WIPRO) and pharmaceuticals (e.g., SUNPHARMA, DRREDDY) that frequently engage in global M&A could see minor, temporary impacts on deal closures. Investment banks and financial services firms (e.g., ICICIBANK, HDFCBANK with their investment banking arms) might experience a slight dip in advisory fees from delayed transactions.

Traders should monitor announcements of specific M&A deals involving Indian companies for any reported delays or renegotiations. Pay attention to quarterly earnings calls for management commentary on M&A pipelines and geopolitical risks. The broader Nifty and Sensex indices are unlikely to be significantly affected by this specific M&A outlook.

• •War with Iran may slow the pace of dealmaking.
• •It is unlikely to dent overall M&A activity.
• •Opinion from Lazard Inc.’s global head of mergers and acquisitions.